Consumption of dietary carotenoids is associated with a decreased risk of cardiovascular disease and cancer. Humans obtain carotenoids in the diet by ingesting fruits and vegetables. Historically, it was thought that the most important role of some carotenoids was their metabolic conversion via cleavage at the central double bond to the essential micronutrient, vitamin A (retinol). There is intense recent interest in the "eccentric cleavage" of dietary carotenoids to apocarotenals and their possible oxidation to apocarotenoic acids. These metabolites of carotenoids may play important roles in the non-vitamin A activities of carotenoids. There are no quantitative analyses of the levels of these compounds in human foods and tissues. Demonstrations of the extent of metabolism of intact carotenoids to these compounds and studies of their mechanisms of action are lacking. We will address these gaps in knowledge. (1) We determine the substrate specificity and characterize the products of the two known human carotenoid-metabolizing enzymes (BCO1 &BCO2). These studies will also establish the relationship of cellular retinol-binding proteins and carotenoid cleavage enzymes in the metabolic function of these enzymes. (2) We will demonstrate the relevance of apocarotenoids in humans using analytical chemistry to characterize the presence and quantify the amounts of apo-carotenals and apocarotenoic acids in human plasma and tissues and in foods. This will be accomplished by quantitation of the immediate post- prandial plasma concentrations of parent carotenoids and metabolites after subjects consume a single serving of tomato juice containing nutritionally relevant amounts of beta-carotene or lycopene as well as by quantitation of steady state concentrations in plasma after 4 weeks of daily consumption. (3) We will use the LNCaP cell, a human prostate cancer cell that demonstrates lycopene-dependent growth inhibition and expresses BCO2 to look for apolycopenals and apolycopenoic acids in lycopene-treated cells to address whether and to what extent lycopene is metabolized in these cells. We will use the human monocyte/macrophage cell, U937, which is growth inhibited and induced to differentiate with carotenoid treatment, to look for metabolism of the parent carotenoids. (4) We will probe the biological (nutritional) function of carotenoid metabolites in multiple ways: (a) we will use cell lines that we have shown have characteristic functional responses to treatment with dietary carotenoids and ask whether these responses are obtained by direct treatment with the cleavage products and (b) we will ask whether these cleavage products and metabolites directly activate or antagonize ligand-dependent transcription factors. (c) We will feed the BCO1 knockout mouse both beta-carotene and lycopene to assess the extent of the metabolism of these carotenoids by BCO2 and the metabolic effects of carotenoid metabolites in the whole animal. The results will enhance our understanding of the molecular basis for the health-promoting effects of diets rich in fruits and vegetables.

Public Health Relevance

Increased consumption of dietary carotenoids is associated with decreased risk of both cardiovascular disease and certain cancers. The proposed research will document the occurrence of new pathways of metabolism of dietary carotenoids (the health-promoting, colored pigments in fruits and vegetables) in humans. The research will also explore possible mechanisms that may explain the basis of the health-promoting effects of these components of the diet.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Ershow, Abby
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Schools of Education
United States
Zip Code
dela Seña, Carlo; Riedl, Kenneth M; Narayanasamy, Sureshbabu et al. (2014) The human enzyme that converts dietary provitamin A carotenoids to vitamin A is a dioxygenase. J Biol Chem 289:13661-6
Eroglu, Abdulkerim; Harrison, Earl H (2013) Carotenoid metabolism in mammals, including man: formation, occurrence, and function of apocarotenoids. J Lipid Res 54:1719-30
Eroglu, Abdulkerim; Hruszkewycz, Damian P; dela Sena, Carlo et al. (2012) Naturally occurring eccentric cleavage products of provitamin A ?-carotene function as antagonists of retinoic acid receptors. J Biol Chem 287:15886-95
Fleshman, Matthew K; Lester, Gene E; Riedl, Ken M et al. (2011) Carotene and novel apocarotenoid concentrations in orange-fleshed Cucumis melo melons: determinations of *-carotene bioaccessibility and bioavailability. J Agric Food Chem 59:4448-54
Reichert, Barbara; Yasmeen, Rumana; Jeyakumar, Shanmugam M et al. (2011) Concerted action of aldehyde dehydrogenases influences depot-specific fat formation. Mol Endocrinol 25:799-809
Shmarakov, Igor; Fleshman, Matthew K; D'Ambrosio, Diana N et al. (2010) Hepatic stellate cells are an important cellular site for *-carotene conversion to retinoid. Arch Biochem Biophys 504:3-10
Marsh, Rebekah S; Yan, Yan; Reed, Vanessa M et al. (2010) {beta}-Apocarotenoids do not significantly activate retinoic acid receptors {alpha} or {beta}. Exp Biol Med (Maywood) 235:342-8
Eroglu, Abdulkerim; Hruszkewycz, Damian P; Curley Jr, Robert W et al. (2010) The eccentric cleavage product of ?-carotene, ?-apo-13-carotenone, functions as an antagonist of RXR?. Arch Biochem Biophys 504:11-6
Novotny, Janet A; Harrison, Dawn J; Pawlosky, Robert et al. (2010) Beta-carotene conversion to vitamin A decreases as the dietary dose increases in humans. J Nutr 140:915-8
Kopec, Rachel E; Riedl, Ken M; Harrison, Earl H et al. (2010) Identification and quantification of apo-lycopenals in fruits, vegetables, and human plasma. J Agric Food Chem 58:3290-6

Showing the most recent 10 out of 24 publications